CIMT & Cancer research Institute: Cancer Vaccine Consortium
Since 2008 CIMT and the Cancer Vaccine Consortium (CVC) of the Cancer research Institute (CRI) have joined forces in different projects. Our CIMT Immunoguiding Program (CIP) has partnered with the CVC to set new standards and harmonize protocols for immunoassays used in cancer immunotherapy studies. Furthermore the CIMT Regulatory Research Group is in dialogue with CVC to address the challenges posed by regulatory rules for clinical development by the new era of individualized medicine.visit website
CIMT & Cancer Immunology Immunotherapy (CII)
The international journal "Cancer Immunology, Immunotherapy" ("CII) is the official partner journal of CIMT. The partnership includes the presentation of scientific contents, such as meeting reports, symposium papers and abstracts.visit website
Deutsche Krebshilfe
The Deutsche Krebshilfe holds the patronage for the annual CIMT meetings.visit website
FZI Mainz
The "Forschungszentrum Immunologie" (FZI) is aiming to support all immunological research activities at the university hospital of Mainz and the Johannes Gutenberg University. The FZI is promoting the exchange between scientists from different fields. It is aiming to increase the visibility of research carried out by FZI partners and additionally coordinates multidisciplinary research activities. CIMT and FZI agreed on a statement of cooperation to foster international visibility and to provide structured education for their partners. The FZI is an official co-organizer of the 8th annual CIMT Meeting in 2010.visit website
